The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients - Petrera, Marilena; Scherer, Dominique; Haefeli, Walter E.; Ulrich, Cornelia (BioMed Central ; Springer, 2018)
Aus: BMC Cancer, 18 (2018), Nr. 1210. pp. 1-9. ISSN 1471-2407